Minerva Surgical Closes $75M IPO

Minerva Surgical, a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), closed its IPO of 6.25 million shares at a public offering price of $12 per share. The aggregate gross proceeds to Minerva Surgical from the offering were $75 million. Read more.

Total
0
Shares
Related Posts
Read More

Validic Hauls in $12M

Kaiser Permanente Ventures led, and was joined by Arkin Digital Health, Green Park and Golf Ventures, Ziegler, Gore Range Capital, Greycroft Partners and SJF Ventures.